AI platform for drug development and discovery

Home AI platform for drug development and discovery
Insilico Medicine, an AI-based platform for drug development and discovery, announced $255 million in Series C financing on Tuesday. The massive round is reflective of a recent breakthrough for the company: proof that its AI-based platform can create a new target for a disease, develop a bespoke molecule to address it and begin the clinical trial process.
Author:liu, tempo/ Date: 2021-07-01 /Views:48